NIBIB-funded engineers are using deep learning to differentiate tumor more accurately from normal tissue in positron emission tomography (PET) images.
Science Highlights · October 18, 2021
Science Highlights · September 22, 2021
NIBIB-funded engineers are using focused ultrasound to modulate motor activity in the brain without surgical device implantation, a first step toward non-invasive brain stimulation therapies.
Science Highlights · September 9, 2021
NIBIB-funded researchers are working on an ankle prosthetic that relies on the user’s residual muscles—and the electrical signals that they generate—to help amputees control their posture continuously.
Science Highlights · September 7, 2021
The gut microbiome can impact us in a variety of different ways, from our metabolism to our mood. Now, NIBIB-funded researchers are investigating if a fiber-based gel can restore beneficial microbes in the gut to enhance the efficacy of immune checkpoint inhibitors, a type of cancer immunotherapy treatment.
Science Highlights · August 26, 2021
Placenta accreta spectrum (PAS) disorder is a life-threatening condition that occurs when the placenta remains attached to the uterus after childbirth. Now researchers have developed a blood test to identify this condition, enabling early intervention by high-risk pregnancy specialists.
Science Highlights · August 13, 2021
NIBIB-funded research drives progress in the diagnosis, treatment, and monitoring of middle ear infections.
Science Highlights · August 11, 2021
Bioengineers have developed biocompatible self-assembling “piezoelectric wafers,” which can be made rapidly and inexpensively to enable broad use of implantable muscle-powered electromechanical therapies.
Science Highlights · August 10, 2021
NIH-funded researchers at Carnegie Mellon University have demonstrated the potential of a neuromodulation approach that uses low-intensity ultrasound energy, called transcranial focused ultrasound—or tFUS.
Science Highlights · July 13, 2021
Nanofiber-based treatments stimulate the body to mount its own biological attack on immune disorders.